Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel C Chambers

Showing results (101-110 of 127) with videos related to

Pageof 13
Sort By:
Thorax|September 24, 2014
Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trialDiana Bilton, Gregory Tino, Alan F Barker, et al.
BMC Pulmonary Medicine|November 11, 2021
High intensity interval training versus moderate intensity continuous training for people with interstitial lung disease: protocol for a randomised controlled trialLeona M Dowman, Anthony K May, Catherine J Hill, et al.
Archives of Dermatological Research|September 5, 2020
Destructive and topical treatments of skin lesions in organ transplant recipients and relation to skin cancerAdele C Green, Mandy Way, Mariella Oster, et al.
Plos One|April 29, 2026
Single-cell transcriptomics of bronchoalveolar lavage reveals divergent macrophage subpopulations and trajectories in interstitial lung diseaseLai-Ying Zhang, Peter C Allen, Viviana P Lutzky, et al.
The European Respiratory Journal|January 8, 2026
Do we need to prioritise interstitial lung disease clinical diagnoses? A comment on the 2025 interstitial pneumonia statementAshley Fraser, Ling-Ling Tsai, Caitlin C Fermoyle, et al.
Transplantation|January 28, 2020
Azithromycin Partially Mitigates Dysregulated Repair of Lung Allograft Small Airway EpitheliumKak-Ming Ling, Luke W Garratt, Balarka Banerjee, et al.
Respirology (Carlton, Vic.)|August 29, 2017
Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation AustraliaHelen E Jo, Lauren K Troy, Gregory Keir, et al.
The Medical Journal of Australia|July 30, 2025
Silicosis research priorities for health care, research, and health and safety professionals, and for people exposed to silica in Australia: a research priority setting exerciseHayley Barnes, Sharna Mathieu, Deborah C Glass, et al.
BMJ Open|December 15, 2020
Ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis (PFOX trial): a randomised controlled trialAnne E Holland, Tamera Corte, Daniel C Chambers, et al.
Respirology (Carlton, Vic.)|January 11, 2024
Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revisionJohn A Mackintosh, Gregory Keir, Lauren K Troy, et al.
Pageof 13

Showing results (101-110 of 127) with videos related to

Sort By:
Pageof 13
Thorax|September 24, 2014
Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trialDiana Bilton, Gregory Tino, Alan F Barker, et al.
BMC Pulmonary Medicine|November 11, 2021
High intensity interval training versus moderate intensity continuous training for people with interstitial lung disease: protocol for a randomised controlled trialLeona M Dowman, Anthony K May, Catherine J Hill, et al.
Archives of Dermatological Research|September 5, 2020
Destructive and topical treatments of skin lesions in organ transplant recipients and relation to skin cancerAdele C Green, Mandy Way, Mariella Oster, et al.
Plos One|April 29, 2026
Single-cell transcriptomics of bronchoalveolar lavage reveals divergent macrophage subpopulations and trajectories in interstitial lung diseaseLai-Ying Zhang, Peter C Allen, Viviana P Lutzky, et al.
The European Respiratory Journal|January 8, 2026
Do we need to prioritise interstitial lung disease clinical diagnoses? A comment on the 2025 interstitial pneumonia statementAshley Fraser, Ling-Ling Tsai, Caitlin C Fermoyle, et al.
Transplantation|January 28, 2020
Azithromycin Partially Mitigates Dysregulated Repair of Lung Allograft Small Airway EpitheliumKak-Ming Ling, Luke W Garratt, Balarka Banerjee, et al.
Respirology (Carlton, Vic.)|August 29, 2017
Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation AustraliaHelen E Jo, Lauren K Troy, Gregory Keir, et al.
The Medical Journal of Australia|July 30, 2025
Silicosis research priorities for health care, research, and health and safety professionals, and for people exposed to silica in Australia: a research priority setting exerciseHayley Barnes, Sharna Mathieu, Deborah C Glass, et al.
BMJ Open|December 15, 2020
Ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis (PFOX trial): a randomised controlled trialAnne E Holland, Tamera Corte, Daniel C Chambers, et al.
Respirology (Carlton, Vic.)|January 11, 2024
Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revisionJohn A Mackintosh, Gregory Keir, Lauren K Troy, et al.
Pageof 13